Zoekresultaten - Su Jeong Park

  • Toon 1 - 3 resultaten van 3
Verfijn jouw resultaten
  1. 1
    The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents

    The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents door Su Jeong Park, In‐ho Song, Gyu Seong Yeom, Satish Balasaheb Nimse

    Gepubliceerd in 2024
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Current status and future direction of metallic and polymeric materials for advanced vascular stents

    Current status and future direction of metallic and polymeric materials for advanced vascular stents door Seung Hyuk Im, Dam Hyeok Im, Su Jeong Park, Youngmee Jung, Dong‐Hwee Kim, Soo Hyun Kim

    Gepubliceerd in 2022
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial door Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp

    Gepubliceerd in 2021
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: